Alumis (ALMS) Assets Average (2024 - 2026)
Alumis' (ALMS) quarterly Assets Average came in at $486.3 million in Q2 2026, up 11.5% year-over-year from $436.1 million in Q2 2025, and up 8.07% quarter-over-quarter from $450.0 million in Q4 2025.
Analysis
Alumis (ALMS) Assets Average (2024 - 2026) Analysis & Trends
Alumis (ALMS) has reported Assets Average for 3 consecutive years, with $486.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Assets Average rose 11.5% year-over-year to $486.3 million in Q2 2026; TTM through Jun 2026 was $486.3 million, a 11.5% increase from a year earlier, with the FY2025 full-year figure at $376.5 million, up 74.85% from the prior year.
- Assets Average was $486.3 million for Q2 2026 at Alumis, up from $450.0 million in the prior quarter.
- Over five years, Assets Average peaked at $549.5 million in Q3 2025 and troughed at $301.1 million in Q1 2025.
- A 3-year average of $419.8 million and a median of $436.1 million in 2025 frame the typical range for Assets Average.
- Across the five-year window, Assets Average surged 62.15% in 2025 and rose 11.5% in 2026, its largest moves.
- Over 3 years, Assets Average stood at $376.8 million in 2024, then grew by 19.43% to $450.0 million in 2025, then climbed by 8.07% to $486.3 million in 2026.
- The last three Assets Average figures came in at $486.3 million (Q2 2026), $450.0 million (Q4 2025), and $549.5 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 94.07 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 52.82 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 26.95 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 41.30 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 11.22 Bn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 30.78 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 5.51 Bn |
| 10 | Alumis | 966.94 Mn | 464.65 Mn | - | 486.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 486.28 Mn |
| Dec 31, 2025 | 449.98 Mn |
| Sep 30, 2025 | 549.47 Mn |
| Jun 30, 2025 | 436.11 Mn |
| Mar 31, 2025 | 301.15 Mn |
| Dec 31, 2024 | 376.78 Mn |
| Sep 30, 2024 | 338.87 Mn |